140 related articles for article (PubMed ID: 695697)
21. Biotransformation of epomediol. I--Isolation and identification of main metabolites in the rat.
Ventura P; Selva A
Biomed Mass Spectrom; 1982 Jan; 9(1):18-21. PubMed ID: 7059659
[TBL] [Abstract][Full Text] [Related]
22. The metabolism and toxicity of halogenated carbanilides. Biliary metabolites of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in the rat.
Jeffcoat AR; Handy RW; Francis MT; Willis S; Wall ME; Birch CG; Hiles RA
Drug Metab Dispos; 1977; 5(2):157-66. PubMed ID: 15808
[TBL] [Abstract][Full Text] [Related]
23. Studies on increased bile formation produced by polyoxybenzenes in rats.
Tanayama S; Kanai Y
Jpn J Pharmacol; 1977 Feb; 27(1):71-8. PubMed ID: 864884
[TBL] [Abstract][Full Text] [Related]
24. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
[TBL] [Abstract][Full Text] [Related]
25. Disposition and metabolism of fenbufen in several laboratory animals.
Chiccarelli FS; Eisner HJ; Van Lear GE
Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
[TBL] [Abstract][Full Text] [Related]
26. Identification of the metabolites of erythro-9-(2-hydroxy-3-nonyl)hypoxanthine from laboratory animals.
Pfadenhauer EH; Bankert CS; Jensen J; Jones CE; Jenkins EE; McCloskey JA
Drug Metab Dispos; 1984; 12(3):280-4. PubMed ID: 6145553
[TBL] [Abstract][Full Text] [Related]
27. [Metabolism and pharmacokinetics of piprozoline in the rat, dog and man. 1. Studies with the radioactively-labeled substance].
Vollmer KO; Hodenberg AV; Poisson A; Bode R; Schauerte E
Arzneimittelforschung; 1977; 27(2b):502-8. PubMed ID: 577412
[TBL] [Abstract][Full Text] [Related]
28. The metabolism of alpha-aminobenzo(b)thiophene-3-propionic acid (the sulfur analog of tryptophan) in the rat.
Bosin TR; Bickers RG; Dinner A
Drug Metab Dispos; 1978; 6(1):31-7. PubMed ID: 23271
[TBL] [Abstract][Full Text] [Related]
29. Tiaprofenic acid overdose.
Köppel C; Wagemann A; Tenczer J; Muth H
Arzneimittelforschung; 1984; 34(7):836-7. PubMed ID: 6333878
[TBL] [Abstract][Full Text] [Related]
30. Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat.
Holzinger F; Schteingart CD; Ton-Nu HT; Eming SA; Monte MJ; Hagey LR; Hofmann AF
Hepatology; 1997 Nov; 26(5):1263-71. PubMed ID: 9362371
[TBL] [Abstract][Full Text] [Related]
31. On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine.
Kraemer T; Bickeboeller-Friedrich J; Maurer HH
Drug Metab Dispos; 2000 Mar; 28(3):339-47. PubMed ID: 10681380
[TBL] [Abstract][Full Text] [Related]
32. Triketocholanoic (dehydrocholic) acid. Hepatic metabolism and effect on bile flow and biliary lipid secretion in man.
Soloway RD; Hofmann AF; Thomas PJ; Schoenfield LJ; Klein PD
J Clin Invest; 1973 Mar; 52(3):715-24. PubMed ID: 4685091
[TBL] [Abstract][Full Text] [Related]
33. Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse.
Vyas KP; Kari PH; Pitzenberger SM; Halpin RA; Ramjit HG; Arison B; Murphy JS; Hoffman WF; Schwartz MS; Ulm EH
Drug Metab Dispos; 1990; 18(2):203-11. PubMed ID: 1971574
[TBL] [Abstract][Full Text] [Related]
34. Identification of ractopamine hydrochloride metabolites excreted in rat bile.
Smith DJ; Giddings JM; Feil VJ; Paulson GD
Xenobiotica; 1995 May; 25(5):511-20. PubMed ID: 7571724
[TBL] [Abstract][Full Text] [Related]
35. The identification of 3-keto-2-methylvaleric acid and 3-hydroxy-2-methylvaleric acid in a patient with propionic acidemia.
Truscott RJ; Pullin CJ; Halpern B; Hammond J; Haan E; Danks DM
Biomed Mass Spectrom; 1979 Jul; 6(7):294-300. PubMed ID: 486715
[TBL] [Abstract][Full Text] [Related]
36. Choleretic and diuretic properties of dihydroxydibutyl ether in the rat.
Corbic M; Dumont M; De Couët G; Erlinger S
J Pharmacol Exp Ther; 1982 Jun; 221(3):769-74. PubMed ID: 7086686
[TBL] [Abstract][Full Text] [Related]
37. The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat.
Bolton GC; Griffiths LA
Drug Metab Dispos; 1979; 7(6):388-92. PubMed ID: 43225
[TBL] [Abstract][Full Text] [Related]
38. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
[TBL] [Abstract][Full Text] [Related]
39. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
40. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver.
Sweeny DJ; Barnes S; Diasio RB
Cancer Res; 1988 Apr; 48(8):2010-4. PubMed ID: 2964897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
